Access Webinar

(you will be asked to sign-in)

To see if you are entitled to get this research for free, take a minute and create a free e-Library account. This will let us determine if someone else at your organization has already purchased access to this material.

Market Access and Adoption of Disruptive Health Technologies

The Conference Board of Canada, April 4, 2018
Recorded Webinar
(You must be signed in and entitled to rate this report)

Early engagement with key stakeholders and collaborative evidence generation play a critical role in expedited market access of disruptive health technologies.

In this 60-minute session, Shahira Bhimani highlights how the EXCITE process supports a “pull model” for innovation adoption wherein the Ontario Ministry of Health and Long-Term Care is integral in the prioritization of the technology based on alignment of the innovation to health system needs. In addition, this presentation discusses case examples of how the EXCITE process uses a multi-stakeholder collaborative process to identify a pathway to adoption of innovative technologies into the Ontario healthcare system.

Webinar Highlights

  • Learn how early engagement with the Ontario health system and alignment of technology with system priorities contributes to greater uptake
  • Discuss an understanding of how implementation planning is instrumental to successful adoption
  • Gain an understanding of which determinants of adoption are key barriers/opportunities that impact implementation pathways
  • Learn how early engagement with the Ontario health system and alignment of technology with system priorities contributes to greater uptake
  • Discuss an understanding of how implementation planning is instrumental to successful adoption
  • Gain an understanding of which determinants of adoption are key barriers/opportunities that impact implementation pathways

About Shahira

Photo of Shahira BhimaniShahira Bhimani is the Director of MaRS EXCITE, an innovative program that focuses on pre-market evidence-based assessment of new, breakthrough health technologies. The focus of MaRS EXCITE is expedited health system adoption of impactful technologies ,through early collaboration between industry, academia, regulators, payers, government and the broader health system. In addition to leading the MaRS EXCITE program, Shahira plays an instrumental role in operationalizing the MaRS EXCITE model globally through her position as Vice President Business Development and Operations for EXCITE International. Shahira also serves in the advisory capacity to medical device innovators within the MaRS portfolio and provides strategic support to these ventures in their commercialization endeavors. Previous to this, as Vice President, Innovation Services at the Health Technology Exchange (HTX), Shahira focused on providing funding opportunities, support services and thought leadership to the Ontario medical device sector and health system at large. With a keen interest in innovation procurement as well as medical device reimbursement in local and international markets, Shahira has developed niche expertise and an extensive network of local and international partners in these realms. Over the years, her broad based knowledge around product development, commercialization and reimbursement of medical devices, has allowed Shahira to provide strategic guidance to innovative medical device companies in developing multi-market access strategies for evidence generation, commercialization and innovation adoption.

Access Webinar

(you will be asked to sign-in)

To see if you are entitled to get this research for free, take a minute and create a free e-Library account. This will let us determine if someone else at your organization has already purchased access to this material.

Update Interests